KBI in the News | AdAlta secures key manufacturing agreements for AD-214
KBI in the News | AdAlta secures key manufacturing agreements for AD-214
Read More
Press Release | KBI Biopharma BVBA Opens in Leuven, Belgium, Offering Analytical Services to the European Market
KBI Biopharma BVBA Opens in Leuven, Belgium, Offering Analytical Services to the European Market
Press Release | ReForm Biologics and KBI Biopharma Announce Strategic Partnership to Improve Biopharmaceutical Formulations and Development
ReForm Biologics and KBI Biopharma Announce Strategic Partnership to Improve Biopharmaceutical Formulations and Development
Press Release | KBI Biopharma Acquires Elion Labs to Further Expand Industry-Leading Biophysical and Analytical Characterization Capabilities
KBI Biopharma Acquires Elion Labs to Further Expand Industry-Leading Biophysical and Analytical Characterization Capabilities
Press Release | KBI Biopharma Acquires Alliance Protein Laboratories, Expands Biophysical Characterization Capabilities
KBI Biopharma Acquires Alliance Protein Laboratories, Expands Biophysical Characterization Capabilities
Press Release | JSR Life Sciences Agrees to Acquire Pioneering Cell Line Developer Selexis SA and Integrate Selexis with KBI Biopharma, Inc.
JSR Life Sciences Agrees to Acquire Pioneering Cell Line Developer Selexis SA and Integrate Selexis with KBI Biopharma, Inc.
Press Release | JSR Life Sciences Expands Manufacturing Capabilities at KBI Biopharma
JSR Life Sciences Expands Manufacturing Capabilities at KBI Biopharma
KBI Biopharma and BriaCell Therapeutics Corp. Enter Cell Therapy Manufacturing Agreement for BriaVax™ Cancer Vaccine
KBI Biopharma and BriaCell Therapeutics Corp. Enter Cell Therapy Manufacturing Agreement for BriaVaxTM Cancer Vaccine
KBI Biopharma Expands Its Services to Include Cell Therapy Manufacturing, Acquires Houston Area Facility
KBI Biopharma Expands Its Services to Include Cell Therapy Manufacturing, Acquires Houston Area Facility
Press | Accelerating Timelines Vital to Securing Slice of Biosimilars Market, KBI
Accelerating timelines vital to securing slice of biosimilars market, KBI